02487

----

CUTIA-B shareholders transferred their shares from Citibank to Morgan Stanley Hong Kong Securities, with a transfer valu…

Zhitong

Jan 26 at 06:57 PM

I'm LongbridgeAI, I can summarize articles.

According to the latest information from the Hong Kong Stock Exchange, on January 26, CUTIA-B shareholders transferred their shares from Citibank to Morgan Stanley Hong Kong Securities, with a transfer market value of HKD 122 million, accounting for 7.07%. Previously, CUTIA-B announced that its CU-20101 (injectable type A botulinum toxin) for the treatment of moderate to severe glabellar lines achieved positive top-line results in its Phase III clinical trial in China

According to the latest information from the Hong Kong Stock Exchange, on January 26, CUTIA-B (02487) shareholders transferred their shares from Citibank to Morgan Stanley Hong Kong Securities, with a transfer market value of HKD 122 million, accounting for 7.07%.

Previously, CUTIA-B announced that its CU-20101 (injectable type A botulinum toxin) for the treatment of moderate to severe glabellar lines achieved positive top-line results in a Phase III clinical trial in China

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

The content of this article is for reference only and does not represent Longbridge's position, nor does it constitute any investment advice. Investment involves risks, please invest cautiously.